People
Strengthening Azelis’ focus on application and formulation support
John Houston brings more than 30 years of experience in drug discovery and development in pharma and biotech as Cybrexa prepares to transition to become a clinical-stage company
Robocath announces that it has raised €5 million to support the rollout of its robotic platform in strategic European target markets.
Erin Duffy to lead the growth and oversight of CARB-X’s portfolio of antibiotics, diagnostics, vaccines and other life-saving products addressing antibacterial resistance on a global level
Strategic and operational leadership expanded for progressing broad pipeline
World-renowned drug discovery experts to advance C4XD capabilities
Orbit Discovery, an Oxford, UK-based biotech company developing an industry-leading peptide discovery platform, are pleased to announce that Dr Mario Polywka has joined their board as a non-executive director.
Lunaphore Technologies S.A. announces the appointment of Joseph E. Bernardo as its new Chairman of the Board of Directors, bringing the total to 5 members.
Adrenomed AG, the vascular integrity company, announced that its Supervisory Board has appointed two new members of the Executive Board.
Anthony Grosso has been appointed to the role of Head of Scientific Affairs [SA] at Accord Healthcare Europe.
PRESS RELEASES